ClinTex

ClinTex

Created using Figma
Created using Figma
ClinTex是一个临床试验协作和信息分析平台,利用分布式账本技术的优势。 ClinTex CTi平台的子结构同时构建了一个生态系统,可以实现所有临床测试信息视图的互操作性,并通过区块链技术,为存储和调查所选历史临床信息视图提供安全环境的独特能力。
PRE ICO
2018年10月1日
2018年11月5日
100% 完成
募集资金 - 无数据
past
  • 1 CLX
    =
    0.1 USD
令牌详细信息
接受的货币
ETH, BTC
公司详情
注册国家
Malta
额外细节
KYC
分类
平台, 健康, 其他

关于 ClinTex

ClinTex是一个临床试验协作和数据分析平台,利用分布式账本技术(区块链)的优势。它利用以太坊公共区块链上的智能合约提供端到端分散式解决方案,该解决方案包含工具,以推动整个行业临床试验数据共享的协作,以及通过先进的临床数据审查进行临床试验的显着质量和运营改进,富有洞察力运营关键绩效指标(KPI),预测数据分析和机器学习(AI)。 ClinTex临床试验智能平台(ClinTex CTi)将极大地改善制药公司’在建立,实施,监督,审查和满足临床试验监管标准方面的运营和临床有效性。 ClinTex CTi平台的基础在于创建一个生态系统,该系统可实现所有临床试验数据视图的互操作性,并通过区块链技术,为存储和分析所选历史临床数据视图提供安全环境的独特能力。通过这种方式,ClinTex CTi平台提供了共享临床数据视图和开发数据分析解决方案的最佳环境,同时解决了所有利益相关方的隐私和安全问题。通过CTi平台,创建了一个由七个独立的分散应用程序组成的生态系统。这些应用程序将共同提供有价值的临床见解,利用新型预测分析工具和机器学习,为临床项目经理,临床试验医师,临床数据管理人员,药物警戒人员和现场监控人员提供便利。

%name%Roadmap

  • Q2 2018

  • CTi Data Model Design;
    CTi-OEM Prototype Development.
  • Q3 2018

  • Pre Sale TGE;
    Public TGE.
  • Q4 2018

  • CTi GUI Development (with Integrated CLX Wallet);
    Blockchain Verification of CTi Pre-Processing Data.
  • Q1 2019

  • Blockchain Verification of CTi Pre-Processing Data;
    CTi-OEM DEvelopment.
  • 阅读更多
  • Q2 2019

  • CTi-PDA Development.
  • Q3 2019

  • CTi-PRR Development;
    Migration on-chain of CTiClinical Data Statistical Summaries.
  • Q4 2019

  • CTi-RBM Development;
    CTi-CDV Development.
  • Q1 2020

  • Cti-VMM Development.
  • Q2 2020

  • CTi-SIM Development.
  • Q3-Q4 2020

  • Migration on-chain of the CTi Data Model and CTi Processing Engine,

活动

关注:
300
VERY LOW
推文:
74
LOW
30天成长:
-4
会员:
28
VERY LOW
30天成长:
-1

ClinTex 球队

验证 9%

注意。未经证实的成员实际上可能不是团队成员

Neill Barron
Director of Clinical Data Services
未验证
Brendan O’Mainnin
Director of Operations
验证
Samandip Dhesi
Medical Officer
未验证
Adrian W. Donoghue
Director of Business Services
未验证
John McCabe
Head of Legal & Regulatory
未验证
Edward Burke
Lead Developer
未验证
Stanislav Sheliakin
Lead DLT Business Architect
未验证
Sean Flanagan
Head of Business Development
未验证
Ethan Diamant
Head of Clinical Services
未验证
Philip O’Neill
Front End UX/UI
未验证
Graham Stone
Content Creator
未验证

顾问

验证 0%

注意。未经证实的成员实际上可能不是团队成员

Sheraz Majeed
Medical Technology Advisor
未验证

4 ICO

$3 082 361

Binod Nirvan
Blockchain Technology Advisor
未验证
Stefan Bergström
Strategic Business Advisor
未验证

6 ICO

$3 922 763

Ihor Pidruchny
Blockchain Development Advisor
未验证
Ciara Barron
Pharmaceutical Development Advisor
未验证
Sean Comiskey
Technology Engineering Advisor
未验证
Dylan Costigan
Security Engineering Advisor
未验证
Omar Zerafa
Legal Advisor
未验证

ClinTex 面试

Brendan O’Mainnin
As a team member, сan you tell us about your role in the ICO project? What do you think about idea?
CTi is the first blockchain enterprise solution that will tackle a critical and current problem in the world with regard to the high cost of medical treatments as a result of clinical trial expenditure.
As a team member, сan you tell us about your role in the ICO project?
I oversee all day-to-day administrative and operational functions of the business, the management of all marketing initiatives and the design of operational strategy for ClinTex.
What do you think about idea?
Pharmaceutical companies can now gain deep insight into the operational and clinical aspects of their trials without the necessity of major investment into backend technical infrastructure or data science expertise

ClinTex 最新消息

N/A
5.0 13
ICO 轮廓 视力 活动 潜在 产品 球队

%name%Reviews

icoexaminer.com
ICO review website

There is enough material to suggest that ClinTex is aiming to address a real need within the clinical trial field. Tokenomics for the project are straightforward with minimal bonuses applicable and a clear team vesting period. The acceptance of Binance coin in the ICO adds another level of interest and, although no partnership is stated or implied, investors may feel it increases the possibility of a future listing opportunity with the exchange.

Maybe most importantly, an able team is backed by experienced advisors and together they have shown the foresight to partner with useful allies within the blockchain arena and realm of medical services.

The downside column is much shorter but it should be noted that there is currently no working product and the roadmap suggests that some of the infrastructure will not be fully available until well into 2020 which could hamper uptake of the platform.

The whitepaper states that one of the reasons ClinTex ClinTex has partnered with Intellimed is that they will “…deploy the CTi platform in academic clinical research settings.”

This suggests that a firm footing for the initial launch of the platform has been established so it is the forward momentum of ClinTex, that includes expected on-boarding of other pharmaceutical companies in mid-2019, that contributors to the ICO will need to judge.

Given that they have first mover advantage in this particular specialised arena, the fundamentals appear to outweigh the minor concern and marks ClinTex as an ICO worthy of serious consideration.

阅读更多
  • 由于信息更新可能存在时间差异,因此应通过其官方网站或其他沟通渠道验证有关每个ICO项目的准确信息。
  • 这些信息不是投资ICO资金的建议或建议。请自行彻底调查相关信息并决定ICO的参与情况。
  • 如果您认为有任何问题需要纠正,或者您想提交自己的ICO项目,请给我们发送电子邮件。
请阅读免责声明和风险警告。 显示免责声明和风险警告。
Planning an ICO? We can help with a wide range of support for all stages of your ICO